E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/6/2020 in the Prospect News Convertibles Daily.

Convertibles Calendar: Pacira BioSciences on tap

July 7 (post-close)

PACIRA BIOSCIENCES INC.:

• $300 million five-year convertible notes

• Greenshoe of $45 million

• Coupon of 0.75% to 1.25% and initial conversion premium of 30% to 35%

• Rule 144A

• J.P. Morgan Securities LLC, Jefferies LLC, RBC Capital Markets Corp. and Piper Sandler Co.

• Non-callable for three years then subject to a 130% hurdle

• Proceeds to repurchase a portion of the company’s 2.375% convertible notes due 2022 in privately negotiated transactions and for general corporate purposes

• Parsippany, N.J.-based pharmaceutical company


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.